This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A systematic review of pathophysiology and management of familial hyperaldosteronism type 1 in pregnancy
Endocrine Open Access 27 May 2021
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ogishima T, Shibata H, Shimada H, Mitani F, Suzuki H, Saruta T et al. Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism. J Biol Chem 1991; 266: 10731–10734.
Wyckoff JA, Seely EW, Hurwitz S, Anderson BF, Lifton RP, Dluhy RG . Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 2000; 35: 668–672.
Mulatero P, di Cella SM, Williams TA, Milan A, Mengozzi G, Chiandussi L et al. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J Clin Endocrinol Metab 2002; 87: 3187–3191.
Hamilton E, O'Callaghan C, O'Brien RM, Stowasser M, Gordon R, Zajac J et al. Familial hyperaldosteronism type 1 in pregnancy. Intern Med J 2009; 39: 135–136.
Goland RS, Conwell IM, Warren WB, Wardlaw SL . Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy. Neuroendocrinology 1992; 56: 742–749.
Quinkler M, Diederich S . Difference of in vivo and in vitro antimineralocorticoid potency of progesterone. Endocr Res 2002; 28: 465–470.
Vecchiola A, Lagos CF, Fuentes CA, Allende F, Campino C, Valdivia C et al. Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro. Reprod Biol Endocrinol 2013; 11: 76–87.
Carvajal CA, Stehr CB, González PA, Riquelme EM, Montero T, Santos MJ et al. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I. J Endocrinol Invest 2011; 34: 140–144.
Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J . Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 2009; 7: 79.
Defaye G, Piffeteau A, Delorme C, Marquet A . Specific inhibition of the last steps of aldosterone biosynthesis by 18-vinylprogesterone in bovine adrenocortical cells. J Steroid Biochem Mol Biol 1996; 57: 141–147.
Acknowledgements
This work was supported by Chilean grants: FONDECYT 1130427, FONDEF IDeA CA12i10150, Millennium Institute of Immunology, Immunotherapy IMII P09/016-F (ICM), CORFO 13CTI-21526-P1 and Sociedad Chilena de Endocrinología y Diabetes. CA Carvajal is a CONICYT (Comisión Nacional de Investigación Científica y Tecnológica de Chile, www.conicyt.cl) fellow.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Campino, C., Trejo, P., Carvajal, C. et al. Pregnancy normalized familial hyperaldosteronism type I: a novel role for progesterone?. J Hum Hypertens 29, 138–139 (2015). https://doi.org/10.1038/jhh.2014.49
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2014.49
This article is cited by
-
Aldosterone and renin concentrations were abnormally elevated in a cohort of normotensive pregnant women
Endocrine (2022)
-
A systematic review of pathophysiology and management of familial hyperaldosteronism type 1 in pregnancy
Endocrine (2021)
-
Insights on the phenotypic heterogenity of 11β-hydroxylase deficiency: clinical and genetic studies in two novel families
Endocrine (2018)